158778-58-6Relevant articles and documents
Improved methods for the synthesis of irbesartan, an antihypertensive active pharmaceutical ingredient
Rao, Korrapati V. V. Prasada,Dandala, Ramesh,Handa, Vijay K.,Rao, Inti V. Subramanyeswara,Rani, Ananta,Naidu, Andra
, p. 2897 - 2905 (2008/02/13)
New methods for the preparation of irbesartan 1 have been described. The dehydration and tetrazole formation in one step from substituted cyclopentane derivative 7 with tributyltin chloride and sodium azide is described. Selective hydrolysis of nitrile 3 with HCl has also been described in the preparation of N-acylaminocyclopentane-2-carboxylic acid 4, which is the key intermediate for the preparation of irbesartan. The impurity profiling of irbesartan has also been discussed. Copyright Taylor & Francis Group, LLC.
A novel approach for the conversion of primary amides into tetrazoles by using tributyltin chloride and sodium azide in the presence of DMF
Prasada Rao, Korrapati V. V.,Dandala, Ramesh,Handa, Vijay K.,Subramanyeswara Rao, Inti V.,Rani, Ananta,Shivashankar, Sripelly,Naidu, Andra
, p. 1289 - 1293 (2008/02/07)
A novel and efficient one-pot synthesis of tetrazole derivatives such as Irbesartan and its analogues has been described from the primary acid amide derivatives. Thus 2-alkyl-3-[p-(o-ami-dophenyl (benzyl]-1.3-diazaspiro[4.4]non- 1-en-4-one derivatives or 4-[α-(acylamino)cyclopentamidomethyl]-2′- carboxamidobiphenyl derivatives were treated with tributyltin chloride and sodium azide in o-xylene in the presence of DMF to afford irbesartan and its analogues without generation of nitriles. The synthesis of these new starting materials is also described, and two of the derivatives have been used as new intermediates in the preparation of irbesartan. Georg Thieme Verlag Stuttgart.
A new entry to antihypertensive active pharmaceutical ingredient, Irbesartan and its analogues
Satyanarayana, Bollikonda,Sumalatha, Yasareni,Sridhar, Chaganti,Venkatraman, Sundaram,Reddy, Padi Pratap
, p. 323 - 328 (2007/10/03)
A new synthesis of Irbesartan, an antihypertensive active pharmaceutical ingredient and its analogues is reported.